Background
==========

Concurrent diseases, multiple pathologies and multimorbidity patterns are topics of increased interest as the world's population ages \[[@B1]\]. Multimorbidity is the coexistence of two or more chronic health problems in the same person at one point in time \[[@B2]\], and multimorbidity patterns are any combination of chronic diseases \[[@B3]\]. Both considerations have important consequences for the individual and for health services \[[@B4]\]. Multimorbidity is a challenge for industrialized countries and can jeopardize the viability of national health systems.

Traditionally, the construct of multimorbidity has been inherently associated with persistent or chronic disease. Methods to measure multimorbidity include disease scores, case-mix systems, indexes and disease counts, the latter being the common method \[[@B5]\]. Far too little attention has been paid to the use of health services and the role of urban or rural residency in patients with multimorbidity \[[@B6],[@B7]\]. Furthermore, the literature lacks comparisons by sex of acute morbidity in patients with multimorbidity in a large population sample \[[@B8],[@B9]\].

The classification of acute and chronic disease remains controversial. Acute disease is characterized by a single or repeated episode of relatively rapid onset and short duration with a recovery to previous stage of activity \[[@B10]\]. Nevertheless, some diseases fall into a grey area. Knowledge of specific acute diseases that may occur more frequently than expected and of the underlying vulnerabilities \[[@B11]\] could help to focus attention on the patients with multimorbidity rather than emphasizing the diseases.

To explore the impact of multimorbidity on affected patients and the consequences for health services, we designed a study to describe multimorbidity by sex and life-stage in a large population sample and to assess the association with acute morbidity, area of residency and use of health services.

Methods
=======

Data source and study population
--------------------------------

Cross-sectional study of adults resident in Catalonia, a Mediterranean region of southern European with 7,434,632 inhabitants (2010 census), 16% of the population of Spain. In Catalonia, 358 primary health care teams (PHCT) comprised of doctors, nurses, social workers and support staff are assigned by geographical area and responsible for the health care of the population in their areas. The Catalan Health Institute (CHI) manages 274 PHCT (76.5%), serving a population of 4,859,725 adults; the remaining PHCT are managed by other providers. Doctors and nurses systematically use electronic health records (EHR) to record diagnoses, prescriptions and other clinical, patient management and administrative activities. The CHI Information System for the Development of Research in Primary Care (SIDIAP) \[[@B12]\] compiles coded clinical information from the EHR system. A subset of SIDIAP records meeting the highest quality criteria for clinical data (SIDIAP-Q) includes 40% of the SIDIAP population (1,936,443 patients), attended by the 1,319 general practitioners (GP) whose data recording scored highest in a validated comparison process. The sample is representative of the general Catalan population in terms of geography, age and sex distributions, according to the official 2010 census \[[@B13]\].

A sample of 1,749,710 patients aged 19 years or older, assigned to 251 PHCT during the period of study (1 January- 31 December 2010), was selected from the SIDIAP-Q database.

Coding of diseases
------------------

International Classification of Diseases (ICD-10) codes were mapped to the International Classification of Primary Care (ICPC-2e-v.4.2, available at: <http://www.kith.no/templates/kith_WebPage____1111.aspx>). R codes (symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified) and Z codes (factors influencing health status and contact with health services) were excluded, resulting in 686 included codes. Each diagnosis was then classified using O'Halloran criteria for chronic disease \[[@B14]\]. We included all 146 diagnoses considered as chronic diseases by O'Halloran criteria: (i) have a duration that has lasted, or is expected to last, at least 6 months; (ii) have a pattern of recurrence or deterioration; (iii) have a poor prognosis and (iv) produce consequences, or sequelae, that have an impact on the individual's quality of life \[[@B14],[@B15]\]. Any disease not meeting the O'Halloran criteria was considered an acute disease.

All results were described with ICPC-2 codes. Diseases were classified as acute if diagnosed during the study period and chronic if recorded as such in EHR as of 31 December 2010.

Outcomes and variables
----------------------

The main outcome was multimorbidity, defined as the coexistence of 2 or more chronic diseases. Secondary outcome was the number of new events of each acute disease. Other variables recorded for each patient were the following: number of all acute diseases (0, 1, 2, \> = 3), sex (male, female), age (young adult, 19 to 24; adult, 25--44; older adult, 45--64; elderly, 65--79; and oldest adult, 80+), number of visits during the study period (0, 1--2, 3--5, 6--10, ≥11), and area of residence (rural if \<10,000 inhabitants and/or population density \<150 people/km^2^, otherwise urban) \[[@B14]\]. Number of all acute diseases (or 0 diseases) and visits (or 0 visits) were categorized as quartiles of the study population. Number of visits was used as a proxy of use of health services and included visits recorded in EHR by GP, nurses or social workers, either at the primary care centre or as home health care.

Statistical analysis
--------------------

Analysis was stratified by sex and age group. Descriptive statistics were used to summarize overall information. Categorical variables were expressed as frequencies (percentage) and continuous as mean (Standard deviation, SD) or median (interquartile range, IQR).

Cumulative incidence of acute morbidity events was calculated as the number of new acute events during the study period divided by the at-risk population in the sample (e.g., if a patient had bronchitis twice in the one-year study period, the total number of events accounted for was 2). We took into account the five acute diseases with the highest cumulative incidence within each stratum. Risk ratios (RR) of multimorbidity vs. non-multimorbidity were calculated for the number of events for each acute disease, using Poisson, negative binomial (if overdispersion was present) or zero inflated (when data had an excess of zero counts) equations, as appropriate. All models were adjusted for number of visits and area of residency.

To determine the most prevalent multimorbidity patterns, all possible combinations of any two chronic diseases and their frequencies were calculated. Observed (O) and expected (E) prevalence of those two chronic diseases with each acute disease was then computed. Expected co-occurrence of diseases was obtained as the product of these prevalences, assuming statistical independence of the diseases concerned. The overlapping of those combinations that presented the highest O/E ratio was reported.

Logistic regression was used to assess the association between multimorbidity and the variables listed above.

All statistical tests were two-sided at the 5% significance level. The analyses were performed using SPSS for Windows, version 18 (SPSS Inc., Chicago, IL, USA), Stata/SE version 11 for Windows (Stata Corp. LP, College Station, TX, USA) and R version 2.15.2 (R Foundation for Statistical Computing, Vienna, Austria).

Ethical considerations
----------------------

The study protocol was approved by the Committee on the Ethics of Clinical Research, Institut Universitari d'Investigació en Atenció Primària (IDIAP) Jordi Gol (Protocol No: P12/28). All data were anonymized and the confidentiality of EHR was respected at all times in accordance with international law.

Results
=======

We included 1,749,710 patients; mean age was 47.4 years (SD: 17.8), 50.7% were female and 16% lived in rural areas. Multimorbidity (≥ 2 diseases) was present in 46.8% (95%CI, 46.7%-46.8%) of the sample, being higher in female (52.3%) than in male (41.1%) and in rural areas (47.6%) than in urban areas (46.6%).

The prevalence of the most common chronic diseases differed by sex below 45: anxiety disorder/anxiety (women aged 19--44); acne (men aged 19--24) and lipid disorder (men aged 25--44). After 45 both sex groups first chronic disease was lipid disorder in 45--64 and uncomplicated hypertension in 65-80+ (Table [1](#T1){ref-type="table"}). Upper respiratory infection acute is the most incident acute disease in all age groups (except in 80+).

###### 

Five highest cumulative incidence of acute and prevalence of chronic diseases by sex and age groups

   **Female**  **Male**                                                                                                                                                                                                                                                                                                                                   
  ------------ -------------------------------- -------------------------------- ------------------ ------------------------------------ ----------------------------------- --------------- ----------------------------------- ---------------------------- ------------------ ------------------------------------ ----------------------------------- ---------------
     19-24     P74                              Anxiety disorder/anxiety state   8.4 (8.2-8.7)      R74                                  Upper respiratory infection acute   9.1 (8.9-9.3)                   S96                 Acne                         7.7 (7.5-7.9)      R74                                  Upper respiratory infection acute   6.9 (6.7-7.1)
      S96      Acne                             7.8 (7.6-8.0)                    R76                Tonsillitis acute                    4.4 (4.3-4.6)                       R96                           Asthma                6.0 (5.8-6.2)                R76                Tonsillitis acute                    3.4 (3.3-3.6)                       
      R96      Asthma                           5.4 (5.2-5.6)                    U71                Cystitis/urinary infection other     4.1 (4.0-4.3)                       P74               Anxiety disorder/anxiety state    3.9 (3.7-4.0)                D73                Gastroenteritis presumed infection   2.9 (2.8-3.0)                       
      T82      Obesity                          5.0 (4.8-5.1)                    D82                Teeth/gum disease                    3.7 (3.5-3.8)                       T82                           Obesity               3.4 (3.3-3.6)                D82                Teeth/gum disease                    2.5 (2.4-2.7)                       
      L85      Acquired deformity of spine      4.6 (4.4-4.8)                    D73                Gastroenteritis presumed infection   3.6 (3.5-3.8)                       L85                 Acquired deformity of spine     3.1 (3.0-3.2)                S16                Bruise/contusion                     2.3 (2.2-2.4)                       
     25-44     P74                              Anxiety disorder/anxiety state   12.2 (12.1-12.3)   R74                                  Upper respiratory infection acute   7.8 (7.7-7.9)                   T93                 Lipid disorder               7.3 (7.2-7.4)      R74                                  Upper respiratory infection acute   5.9 (5.8-5.9)
      P76      Depressive disorder              8.8 (8.7-8.9)                    L03                Low back symptom/complaint           3.4 (3.3-3.5)                       P74               Anxiety disorder/anxiety state    6.5 (6.4-6.6)                D73                Gastroenteritis presumed infection   2.4 (2.4-2.5)                       
      T82      Obesity                          6.8 (6.7-6.9)                    U71                Cystitis/urinary infection other     2.9 (2.8-2.9)                       T82                           Obesity               4.4 (4.4-4.5)                L03                Low back symptom/complaint           2.4 (2.3-2.4)                       
      T93      Lipid disorder                   5.0 (4.9-5.0)                    D73                Gastroenteritis presumed infection   2.8 (2.8-2.9)                       P76                     Depressive disorder         3.7 (3.7-3.8)                D82                Teeth/gum disease                    2.1 (2.1-2.2)                       
      N89      Migraine                         4.9 (4.8-4.9)                    R76                Tonsillitis acute                    2.6 (2.6-2.7)                       L86              Back syndrome with radiating pain  3.5 (3.4-3.5)                R76                Tonsillitis acute                    1.8 (1.8-1.9)                       
     45-64     T93                              Lipid disorder                   28.4 (28.2-28.5)   R74                                  Upper respiratory infection acute   7.0 (6.9-7.1)                   T93                 Lipid disorder               29.9 (29.7-30.1)   R74                                  Upper respiratory infection acute   4.8 (4.7-4.9)
      K86      Hypertension uncomplicated       21.2 (21.1-21.4)                 L03                Low back symptom/complaint           3.2 (3.1-3.3)                       K86                 Hypertension uncomplicated      24.6 (24.4-24.7)             L03                Low back symptom/complaint           2.6 (2.5-2.7)                       
      P76      Depressive disorder              18.9 (18.8-19.1)                 U71                Cystitis/urinary infection other     2.9 (2.8-3.0)                       T82                           Obesity               10.9 (10.8-11.0)             R78                Acute bronchitis/bronchiolitis       2.0 (2.0-2.1)                       
      T82      Obesity                          15.7 (15.6-15.9)                 R78                Acute bronchitis/bronchiolitis       2.8 (2.7-2.9)                       T90               Diabetes non-insulin dependent    10.3 (10.2-10.5)             D82                Teeth/gum disease                    2.0 (2.0-2.1)                       
      P74      Anxiety disorder/anxiety state   13.5 (13.4-13.6)                 L20                Joint symptom/complaint NOS          2.6 (2.6-2.7)                       L86              Back syndrome with radiating pain  7.6 (7.5-7.7)                H81                Excessive ear wax                    1.9 (1.9-2.0)                       
     65-79     K86                              Hypertension uncomplicated       60.3 (60.0-60.6)   R74                                  Upper respiratory infection acute   7.2 (7.1-7.3)                   K86                 Hypertension uncomplicated   56.2 (55.9-56.5)   R74                                  Upper respiratory infection acute   6.4 (6.2-6.5)
      T93      Lipid disorder                   52.4 (52.1-52.7)                 U71                Cystitis/urinary infection other     4.3 (4.2-4.4)                       T93                       Lipid disorder            44.6 (44.3-44.9)             H81                Excessive ear wax                    3.9 (3.8-4.0)                       
      T82      Obesity                          24.9 (24.7-25.1)                 R78                Acute bronchitis/bronchiolitis       3.8 (3.7-3.9)                       Y85                Benign prostatic hypertrophy     28.4 (28.1-28.7)             R78                Acute bronchitis/bronchiolitis       3.5 (3.4-3.6)                       
      L95      Osteoporosis                     22.8 (22.5-23.0)                 H81                Excessive ear wax                    3.0 (2.9-3.1)                       T90               Diabetes non-insulin dependent    25.6 (25.4-25.9)             D82                Teeth/gum disease                    2.4 (2.3-2.5)                       
      P76      Depressive disorder              22.3 (22.1-22.5)                 L03                Low back symptom/complaint           2.8 (2.7-2.9)                       T82                           Obesity               15.4 (15.2-15.6)             L03                Low back symptom/complaint           2.3 (2.2-2.4)                       
      80+      K86                              Hypertension uncomplicated       73.1 (72.7-73.4)   R74                                  Upper respiratory infection acute   5.1 (4.9-5.2)                   K86                 Hypertension uncomplicated   63.4 (62.9-63.9)   H81                                  Excessive ear wax                   5.8 (5.6-6.1)
      T93      Lipid disorder                   44.5 (44.1-44.9)                 U71                Cystitis/urinary infection other     5.0 (4.9-5.2)                       Y85                Benign prostatic hypertrophy     37.3 (36.8-37.8)             R74                Upper respiratory infection acute    5.4 (5.1-5.6)                       
      L91      Osteoarthrosis other             25.7 (25.4-26.1)                 R78                Acute bronchitis/bronchiolitis       4.5 (4.4-4.7)                       T93                       Lipid disorder            35.0 (34.5-35.5)             R78                Acute bronchitis/bronchiolitis       4.9 (4.7-5.2)                       
      F92      Cataract                         23.5 (23.2-23.8)                 H81                Excessive ear wax                    4.2 (4.0-4.4)                       T90               Diabetes non-insulin dependent    25.4 (24.9-25.9)             S18                Laceration/cut                       3.8 (3.6-4.0)                       
      T90      Diabetes non-insulin dependent   22.8 (22.5-23.1)                 S18                Laceration/cut                       3.4 (3.3-3.6)                       F92                          Cataract               21.9 (21.4-22.3)             U71                Cystitis/urinary infection other     2.7 (2.6-2.9)                       

*Abbreviations:* ICPC 2 International Classification of Primary Care, CI Confidence interval.

Multimorbidity prevalence increased as age increased, being higher in female (ranged from 19.0% to 92.1%) than male (ranged from 12.9% to 92.0%). In patients with multimorbidity, the number of acute diseases was higher in female than male and decreased as age increased, except in male older than 65. In addition, the number of visits increased as age increased, and was higher for female than male in all age groups except 80+ (Table [2](#T2){ref-type="table"}).

###### 

Multimorbidity prevalence and acute diseases, area of residency and visits according to multimorbidity status stratified by sex and age groups

                             **Female**                                                                                                                                                                                                                         
  -------------------------- ----------------------- ------------------------ ------------------------ ------------------------- ------------------------- ------------------------- ------------------------ ------------------------ ------------------------ ----------------------
   Number of acute diseases                                                                                                                                                                                                                                      
         *Median (IQR)*      *1 (0--2)*              *0 (0--1)*               *1 (0--2)*               *0 (0--1)*                *1 (0-2)*                 *0 (0--1)*                *1 (0--1)*               *0 (0--0)*               *0 (0--1)*               *0 (0--0)*
              0              36.4                    55.3                     40.2                     60.3                      44.8                      68.2                      47.7                     78.0                     51.5                     82.3
              1              26.8                    23.7                     27.1                     22.3                      27.6                      19.4                      27.4                     14.9                     26.2                     12.3
              2              16.9                    11.6                     16.1                     10.2                      14.7                      7.8                       13.7                     4.9                      12.7                     3.7
              ≥3             19.9                    9.4                      16.6                     7.2                       12.9                      4.6                       11.2                     2.3                      9.7                      1.8
    Living in a rural area   14.4                    14.9                     15.3                     15.1                      15.4                      16.7                      15.4                     17.6                     18.4                     18.7
       Number of visits                                                                                                                                                                                                                                          
         *Median (IQR)*      *6 (3--10)*             *2 (0--5)*               *6 (3--11)*              *2 (0--5)*                *8 (4--13)*               *2 (0--5)*                *11 (7--18)*             *2 (0--5)*               *14 (8--24)*             *1 (0--7)*
              0              8.8                     28.4                     9.8                      34.2                      5.8                       38.3                      2.6                      38.9                     3.0                      40.4
             1-2             15.4                    24.4                     14.7                     22.9                      10.4                      21.6                      4.4                      18.6                     4.2                      16.2
             3-5             25.0                    23.6                     23.1                     21.5                      20.5                      20.1                      11.9                     18.0                     9.1                      14.0
             6-10            27.1                    15.8                     26.7                     14.5                      28.7                      13.5                      26.5                     15.5                     20.4                     13.4
             ≥11             23.6                    7.8                      25.7                     6.9                       34.6                      6.4                       54.7                     9.0                      63.4                     16.0
                             **Male**                                                                                                                                                                                                                           
                             **19-24**               **25-44**                **45-64**                **65-79**                 **≥80**                                                                                                                        
                             **MM**                  **Non-MM**               **MM**                   **Non-MM**                **MM**                    **Non-MM**                **MM**                   **Non-MM**               **MM**                   **Non-MM**
                             **n = 8,916 (12.9%)**   **n = 60,373 (87.1%)**   **n = 75,556 (19.5%)**   **n = 311,124 (80.5%)**   **n = 139,776 (54.0%)**   **n = 119,008 (46.0%)**   **n = 97,044 (86.9%)**   **n = 14,584 (13.1%)**   **n = 32,773 (92.0%)**   **n = 2,948 (8.0%)**
   Number of acute diseases                                                                                                                                                                                                                                      
         *Median (IQR)*      *1 (0--1)*              *0 (0--1)*               *0 (0--1)*               *0 (0--1)*                *0 (0--1)*                *0 (0--1)*                *0 (0--1)*               *0 (0--0)*               *0 (0--1)*               *0 (0--0)*
              0              49.0                    64.6                     50.8                     68.1                      55.3                      74.0                      53.2                     76.4                     52.0                     78.9
              1              26.1                    21.7                     26.4                     20.0                      26.0                      17.3                      26.9                     16.0                     27.1                     13.7
              2              13.7                    8.4                      12.8                     7.6                       11.3                      5.9                       12.0                     5.3                      11.9                     4.6
              ≥3             11.1                    5.2                      10.0                     4.4                       7.4                       2.8                       8.0                      2.3                      8.9                      2.8
    Living in a rural area   15.0                    15.1                     15.6                     15.3                      17.3                      17.5                      16.7                     18.8                     21.3                     21.5
       Number of visits                                                                                                                                                                                                                                          
         *Median (IQR)*      *4 (1--8)*              *1 (0--4)*               *5 (2--9)*               *1 (0--3)*                *6 (3--12)*               *1 (0--3)*                *11 (6--17)*             *2 (0--6)*               *14 (8--24)*             *2 (0--8)*
              0              15.0                    38.7                     14.2                     43.8                      8.9                       46.1                      2.8                      36.0                     2.3                      35.2
             1-2             21.6                    26.3                     18.4                     24.0                      13.4                      21.7                      5.3                      19.4                     3.5                      16.3
             3-5             26.1                    19.8                     24.4                     18.0                      22.1                      17.1                      13.4                     18.8                     8.8                      15.5
             6-10            22.5                    10.8                     23.2                     10.0                      26.9                      10.3                      28.1                     16.1                     20.8                     14.2
             ≥11             14.8                    4.4                      19.8                     4.2                       28.7                      4.7                       50.4                     9.7                      64.5                     18.8

*Abbreviations:* MM multimorbidity, IQR interquartile range. Data are expressed as percentage, unless otherwise stated.

Patients with multimorbidity had a higher incidence of acute diseases and number of visits in all age strata than non-multimorbidity patients; in both cases, the incidence was higher for female than male (Table [2](#T2){ref-type="table"}). Overall, the median (IQR) of number of visits was 8(4--14) in patients with multimorbidity vs. 1(0--4) in the non-multimorbidity group.

The two most prevalent combinations of two chronic diseases were hypertension and lipid disorders in patients older than 45 years. The only acute disease that appeared in both sexes was "bursitis/tendinitis/synovitis NOS" in the oldest age group (80+). In the other age groups, the acute health disease varied by sex (Figure [1](#F1){ref-type="fig"}).

![**Most prevalent multimorbidity patterns of two chronic diseases and the corresponding acute disease with the highest observed/expected ratio**^**\***^**, by sex and age groups.**](1471-2296-15-55-1){#F1}

The five acute diseases with the highest cumulative incidence were similar by sex in any age group. Infections were the most common diagnosis. Cystitis/urinary infection was present among the five most prevalent acute conditions only in women and in the oldest men. In women, the highest significant RR of multimorbidity vs. non-multimorbidity was found for teeth/gum disease (aged 19--24) and upper respiratory infection, acute (80+). In men, this RR was only positive and significant for teeth/gum disease (aged 65--79) (Table [3](#T3){ref-type="table"}).

###### 

**Cumulative incidence and risk ratio (RR) of multimorbidity for the five acute diseases with the highest cumulative incidence by sex and age groups\***^**\#**^

   **Female**  **Male**                                                                                                                                                                                                                                        
  ------------ ------------------------------------- ------------------------------------ ------ ---------- ----------------- ----------------- ------------------------------------- ------------------------------------ ------ ---------- ----------------- -----------------
     19-24     R74                                   Upper respiratory infection, acute   16.2   8.8        **1.10**          **(1.04-1.16)**                    R74                  Upper respiratory infection, acute   11.9   7.0        0.96              (0.89-1.03)
      R76      Tonsillitis, acute                    6.7                                  4.3    0.94       (0.86-1.02)       R76                        Tonsillitis, acute           5.5                                  3.4    0.92       (0.83-1.02)       
      U71      Cystitis/urinary infection, other     6.3                                  4.1    **0.85**   **(0.78-0.93)**   D73                Gastroenteritis, presumed infection  4.8                                  2.8    0.93       (0.83-1.04)       
      D82      Teeth/gum disease                     6.2                                  3.6    **1.14**   **(1.04-1.25)**   D82                         Teeth/gum disease           4.3                                  2.7    **0.63**   **(0.44-0.89)**   
      D73      Gastroenteritis, presumed infection   6.3                                  3.4    1.06       (0.97-1.16)       S16                         Bruise/contusion            3.2                                  2.4    **0.75**   **(0.66-0.86)**   
     25-44     R74                                   Upper respiratory infection, acute   12.8   6.9        1.01              (0.98-1.03)                        R74                  Upper respiratory infection, acute   9.9    5.7        **0.85**          **(0.82-0.87)**
      L03      Low back symptom/complaint            4.4                                  3.1    **0.73**   **(0.71-0.76)**   D73                Gastroenteritis, presumed infection  3.8                                  2.3    **0.79**   **(0.76-0.83)**   
      U71      Cystitis/urinary infection other      4.4                                  2.6    **0.86**   **(0.83-0.90)**   L03                    Low back symptom/complaint       3.5                                  2.2    **0.75**   **(0.71-0.78)**   
      D73      Gastroenteritis presumed infection    4.3                                  2.5    **0.90**   **(0.87-0.94)**   D82                         Teeth/gum disease           3.5                                  2.2    **0.82**   **(0.72-0.93)**   
      R76      Tonsillitis, acute                    3.6                                  2.5    1.08       (0.91-1.29)       R76                        Tonsillitis, acute           2.4                                  1.8    **0.69**   **(0.65-0.73)**   
     45-64     R74                                   Upper respiratory infection, acute   9.7    4.5        **0.92**          **(0.88-0.95)**                    R74                  Upper respiratory infection, acute   6.7    3.4        **0.79**          **(0.76-0.82)**
      L03      Low back symptom/complaint            3.9                                  2.1    **0.78**   **(0.74-0.82)**   L03                    Low back symptom/complaint       3.2                                  2.1    **0.58**   **(0.55-0.62)**   
      U71      Cystitis/urinary infection, other     4.0                                  1.7    **0.86**   **(0.81-0.92)**   R78                  Acute bronchitis/bronchiolitis     3.0                                  1.3    **0.86**   **(0.80-0.92)**   
      R78      Acute bronchitis/bronchiolitis        3.9                                  1.6    0.95       (0.89-1.01)       D82                         Teeth/gum disease           2.9                                  1.6    **0.83**   **(0.70-0.98)**   
      L20      Joint symptom/complaint NOS           3.3                                  1.5    0.97       (0.82-1.15)       H81                         Excessive ear wax           2.5                                  1.4    **0.74**   **(0.69-0.78)**   
     65-79     R74                                   Upper respiratory infection, acute   8.4    3.2        0.92              (0.70-1.20)                        R74                  Upper respiratory infection, acute   7.6    3.3        0.93              (0.84-1.03)
      U71      Cystitis/urinary infection other      5.1                                  1.4    1.09       (0.91-1.30)       H81                         Excessive ear wax           4.4                                  2.3    **0.74**   **(0.65-0.83)**   
      R78      Acute bronchitis/bronchiolitis        4.5                                  1.3    0.71       (0.36-1.39)       R78                  Acute bronchitis/bronchiolitis     4.2                                  1.5    0.99       (0.85-1.14)       
      H81      Excessive ear wax                     3.3                                  1.2    0.88       (0.74-1.04)       D82                         Teeth/gum disease           2.9                                  1.2    **1.31**   **(1.10-1.57)**   
      L03      Low back symptom/complaint            3.0                                  1.1    0.76       (0.54-1.07)       L03                    Low back symptom/complaint       2.5                                  1.1    0.87       (0.73-1.03)       
      80+      R74                                   Upper respiratory infection, acute   5.8    1.5        **1.47**          **(1.16-1.86)**                    H81                  Excessive ear wax                    6.5    2.7        0.98              (0.77-1.24)
      U71      Cystitis/urinary infection, other     5.9                                  1.5    **1.40**   **(1.10-1.78)**   R74                Upper respiratory infection, acute   6.2                                  2.0    1.29       (0.98-1.70)       
      R78      Acute bronchitis/bronchiolitis        5.3                                  2.0    0.99       (0.80-1.23)       R78                  Acute bronchitis/bronchiolitis     5.7                                  2.0    1.06       (0.80-1.40)       
      H81      Excessive ear wax                     4.7                                  1.3    **1.34**   **(1.04-1.73)**   S18                          Laceration/cut             4.3                                  2      **0.75**   **(0.57-0.99)**   
      S18      Laceration/cut                        3.9                                  1.6    **0.78**   **(0.61-0.99)**   U71                 Cystitis/urinary infection, other   3.0                                  1.5    0.73       (0.53-1.01)       

*Abbreviations:* MM multimorbidity, RR risk ratio, ICPC 2 International Classification of Primary Care, CI Cumulative incidence, NOS not otherwise specified.

\*Cumulative incicidence was calculated as the sum of the number of new acute events during the study period divided by the 2010 population (e.g. if a patient passed two bronchitis in one year. the total number of events accounted for was two).

^\#^The outcome is the number of acute diseases in each person for each acute disease considered. RR of multimorbidity versus non-multimorbidity was calculated by Poisson, negative binomial (if overdispersion is present) or zero inflated (when data showed excess of zero counts) equation as appropriate and adjusted for number of visits and area of residency. In bold P \< 0.05.

The adjusted analysis of factors associated with multimorbidity showed that the oldest patients (80+ years) with acute diseases and women aged 65--79 with 3 or more acute diseases were more likely to have multimorbidity than patients with no acute diseases. This positive association was only significant in women. Living in a rural area was significantly associated with lower probability of having multimorbidity. Patients who visited a GP more often were more likely than those without visits to have multimorbidity, reaching the highest probability in those aged 65--79 years (Table [4](#T4){ref-type="table"}).

###### 

Factors associated with multimorbidity by sex and age groups

  **Female**                                                                                                                                                                                                          
  ----------------------------------- ----------- ------------ ------------- ----------- ------------- ------------- -------- ------------- ------------- -------- ------------- ------------- -------- ------------- -------------
  *Number of acute diseases(ref.0)*                            0.030                                   \<0.001                              \<0.001                              \<0.001                              \<0.001
  1                                   0.94        0.89-0.99                  0.88        0.86-0.90                   0.82     0.80-0.84                   0.98     0.92-1.03                   1.16     1.05-1.28      
  2                                   0.95        0.89-1.01                  0.86        0.83-0.88                   0.76     0.73-0.78                   1.05     0.96-1.15                   1.54     1.31-1.80      
  ≥3                                  1.02        0.95-1.09                  0.89        0.87-0.92                   0.78     0.75-0.81                   1.29     1.14-1.46                   1.99     1.59-2.47      
  *Rural area (ref. urban)*           0.94        0.89-0.99    0.025         0.94        0.92-0.96     \<0.001       0.80     0.78-0.82     \<0.001       0.69     0.65-0.73     \<0.001       0.76     0.70-0.83     \<0.001
  *Number of visits (ref. 0)*                                  \<0.001                                 \<0.001                              \<0.001                              \<0.001                              \<0.001
  1-2                                 2.09        1.93-2.26                  2.34        2.28-2.14                   3.40     3.30-3.51                   3.62     3.38-3.87                   3.41     3.08-3.78      
  3-5                                 3.52        3.25-3.80                  4.04        3.93-4.15                   7.54     7.31-7.77                   10.18    9.54-10.86                  8.36     7.55-9.27      
  6-10                                5.69        5.25-6.17                  7.11        6.91-7.32                   16.28    15.76-16.81                 25.98    24.28-27.80                 18.86    16.99-20.94    
  ≥11                                 9.93        9.09-10.85                 14.52       14.05-14.99                 43.03    41.39-44.73                 90.81    83.74-98.48                 45.19    40.69-50.19    
  **Male**                                                                                                                                                                                                            
                                      **19-24**   **25-44**    **45-64**     **65-79**   **80+**                                                                                                                      
                                      **OR**      **95% CI**   **P-value**   **OR**      **95% CI**    **P-value**   **OR**   **95% CI**    **P-value**   **OR**   **95% CI**    **P-value**   **OR**   **95% CI**    **P-value**
  *Number of acute diseases(ref.0)*                            \<0.001                                 \<0.001                              \<0.001                              \<0.001                              0.590
  1                                   0.78        0.73-0.83                  0.71        0.70-0.73                   0.67     0.65-0.69                   0.84     0.80-0.89                   1.07     0.95-1.21      
  2                                   0.79        0.73-0.86                  0.64        0.62-0.66                   0.58     0.56-0.60                   0.78     0.72-0.85                   1.08     0.89-1.31      
  ≥3                                  0.76        0.69-0.83                  0.60        0.58-0.62                   0.55     0.52-0.57                   0.86     0.77-0.97                   1.12     0.88-1.42      
  *Rural area (ref. urban)*           0.94        0.88-1.00    0.045         0.95        0.93-0.97     \<0.001       0.87     0.85-0.89     \<0.001       0.71     0.68-0.75     \<0.001       0.79     0.71-0.88     \<0.001
  *Number of visits (ref. 0)*                                  \<0.001                                 \<0.001                              \<0.001                              \<0.001                              \<0.001
  1-2                                 2.32        2.15-2.50                  2.67        2.60-2.75                   3.57     3.47-3.67                   3.58     3.35-3.82                   3.33     2.89-3.85      
  3-5                                 3.93        3.64-4.25                  5.18        5.04-5.33                   8.20     7.97-8.43                   9.66     9.06-10.30                  8.62     7.50-9.92      
  6-10                                6.51        5.97-7.09                  9.62        9.33-9.92                   17.78    17.24-18.34                 24.51    22.93-26.19                 22.07    19.13-25.47    
  ≥11                                 10.86       9.82-12.01                 20.58       19.86-21.32                 45.13    43.43-46.90                 76.41    70.68-82.60                 51.32    44.49-59.19    

Logistic regression.

*Abbreviations:* OR odds ratio, CI confidence interval, ref. reference.

Discussion
==========

Statement of principal findings
-------------------------------

Almost half of the study population had multimorbidity, with infections (mainly acute upper respiratory infection) the most common acute disease in both sexes and all age groups. The most frequent multimorbidity pattern of chronic diseases was the combination of hypertension and dyslipidemia in adults over 45 years of age.

We observed a decrease in the number of acute diseases recorded as age increased. Nonetheless, in adjusted models female older than 65 who had acute diseases were more likely to have multimorbidity.

Finally, the use of health services was positively associated with a diagnosis of multimorbidity. Living in a rural area decreased the probability of multimorbidity.

Strengths and weaknesses of the study
-------------------------------------

A major strength of this study is the analysis of a large, high-quality database of primary-care records, representative of a large population. In the context of a national health system with universal coverage, EHR data have been shown to yield more reliable and representative conclusions than those derived from survey-based studies \[[@B16]\]. Another important strength was the inclusion of all chronic and acute diagnoses registered in EHR, which contributed to a more accurate analysis of the association between acute and chronic diseases and of the disease combinations present in multimorbidity in this population. To synthesize the results, we present here only the most frequent combinations. Finally, few studies have incorporated acute diseases in the study of multimorbidity patterns \[[@B8]\] and none analyzed the relationship between multimorbidity and acute morbidity.

Some possible biases could have influenced our results. First, diseases could be underreported, especially for male of normal workforce age who tend to see their doctors less often than other strata of patients. This effect would diminish in the two oldest age groups because of the retirement age (65 years) in Spain. In patients with multimorbidity, the true incidence of acute disease could be underreported because the GP would place higher priority on the chronic problems in these patients. On the other hand, there could be an over-representation of chronic diagnoses (e.g., hypertension, diabetes, hyperlipidemia, etc.) that are included in the goals/incentives contracts of Catalan PHCT.

The diseases that form part of the CatSalut treatment objectives may be more carefully recorded than other conditions. However, these same diseases are the most prevalent (high blood pressure, diabetes, hypercholesterolemia, smoking, dyslipidemia, ischemic heart disease, atrial fibrillation) and therefore have the greatest impact on population health. The quality-recorders database (SIDIAP-Q) used in this study minimizes the under-reporting of diseases not included in the CatSalut objectives.

Furthermore, the stratified analysis allows more accurate estimation within each age-sex strata and universal access to free health care and medications makes it more likely that patients seeking care will acquire a diagnosis, either acute or chronic \[[@B17],[@B18]\]. Second, there is no universally accepted criterion for consensus classification of acute and chronic disease. This lack of accurate case definitions impedes the establishment of the true incidence/prevalence of a disease \[[@B19]\]. Finally, a residual confounding cannot be completely excluded, and could occur because of epidemiological factors not considered in this study, such as patients' socioeconomic status \[[@B20]\].

Strengths and weaknesses in relation to other studies
-----------------------------------------------------

The estimated multimorbidity prevalence in our sample is higher than in other European studies \[[@B21]-[@B24]\], perhaps because of the analysis of a greater number of diseases in our study than in most other published studies \[[@B25]\]. Nonetheless, the patterns of multimorbidity observed were similar to those observed in other studies \[[@B26]\].

As in other studies, multimorbidity was more prevalent among female \[[@B21],[@B22],[@B24]\]. This could be due to the longer female life expectancy and worse health status, compared to male, differences that are due to both biological and social factors \[[@B26]\]. In addition, sex is a social determinant that influences health status, health behaviours and the use of health services \[[@B27]-[@B30]\]. Recent studies, however, suggest a dismantling of this paradigm based on sex-stratified analysis of consultations for common symptoms \[[@B31]\].

Acute problems are time-consuming for health professional \[[@B32]\], and therefore should be considered part of the primary care workload. Although current health policy, health care services, and research are all heavily focused on chronic diseases, we must not forget that 41% of primary care visits are motivated by an acute disease \[[@B33]\]. The incidence of acute diseases observed in our study concurs with other reports of acute upper respiratory infection and other health problems of infectious aetiology (acute tonsillitis, cystitis) as the primary reasons for seeking primary care, along with non-infectious diseases such as dorsalgia \[[@B33],[@B34]\].

Our study observed a higher prevalence of multimorbidity in rural settings. Other studies conducted in rural areas have reported only a greater prevalence of multimorbidity in elderly people \[[@B6],[@B7]\]. Nonetheless, our adjusted analysis showed that living in a rural area is negatively associated with multimorbidity. This phenomenon could be due to the environmental and sociocultural context and access to both public and private services \[[@B28]\].

Implications for clinicians and policymakers
--------------------------------------------

Our study considered multimorbidity in patients who received primary medical care, considering all visits and diagnoses (acute and chronic diseases). This approach allowed the identification of vulnerable subgroups in our population. A major advantage of our methodology is the use of data obtained directly from standard clinical practice. Knowing the distribution of acute and chronic diseases by life-stage and sex will help the clinician faced with a particular patient to anticipate disease patterns based on the patient's sex and stage of life, recognizing that these vary with age. This will encourage the implementation of personalized disease prevention and health promotion activities.

At the level of health policy and health care administration, the organization of services should be reviewed to ensure that continuity and coordination of patient care are guaranteed; current evidence suggests the potential for improvement in this regard \[[@B35]\].

Unanswered questions and future research
----------------------------------------

The classification of chronic and acute disease remains unresolved, and there is no consensus on the type and number of chronic diseases that define multimorbidity. A personalized measure to determine the severity of diagnosed multimorbidity is also needed.

If longitudinal studies confirm a higher incidence of morbidity in patients with multimorbidity, evidence-based interventions will be needed to prevent the onset of acute disease. Further studies are needed to study possible genetic and pathophysiological explanations that corroborate the observed multimorbidity patterns.

In-depth analysis of other contextual factors related to multimorbidity is also required, along with studies of the relationship between area of residence and multimorbidity and of the differences in health status that may exist between different territories. Finally, there is a need for the implementation and evaluation of health literacy and self-management interventions to improve patient competence in resolving routine acute diseases, which in turn will decrease the care burden in primary care systems.

Conclusions
===========

Multimorbidity is related to more use of health services and higher incidence of acute diseases, which increases the burden on primary care services. Residence in urban vs rural settings is a factor for future in-depth study.

The association of acute morbidity, area of residency or use of health services with multimorbidity differs according to life-stage and sex. Therefore, the study of multimorbidity should be stratified by life-stage and sex. Understanding these trends across life-stages will allow health systems to adjust their clinical and management models to adapt and prioritize interventions.
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